UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported) February 27, 2008
________________________
WEST PHARMACEUTICAL SERVICES, INC.
.
(Exact name of registrant as specified in its charter)
_____________________
|
|
|
Pennsylvania |
1-8036 |
23-1210010 |
(State or other jurisdiction |
(Commission File Number) |
(IRS Employer Identification No.) |
|
|
|
101 Gordon Drive, PO Box 645, Lionville, PA |
|
19341-0645 |
(Address of principal executive offices) |
|
(Zip Code) |
610-594-3319
(Registrants telephone number, including area code)
Not Applicable
(Former name or address, if changed since last report)
____________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01 |
Other Events. |
On February 27, 2008, the Companys Board of Directors issued a press release announcing that the Company had repurchased 980,300 shares of its common stock at an average price of $40.23 per share since the announcement of a one million share repurchase program on August 8, 2007. There are no plans for further share repurchase at this time. The press release announcing this is included as an Exhibit hereto and is incorporated herein by reference. |
Item 9.01 |
Financial Statements and Exhibits. | ||
(d) |
Exhibits. |
|
|
|
|
|
|
|
Exhibit # |
Description |
|
|
99.1 |
West Pharmaceutical Services, Inc. Press Release, dated February 27, 2008. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
WEST PHARMACEUTICAL SERVICES, INC. |
|
/s/ John R. Gailey III |
John R. Gailey III |
Vice President, General Counsel and Secretary |
February 29, 2008